Clinical trial leaders, now more than ever, are expected to effectively increase capacity and accelerate operations without expanding budgets or their workforce. This new demand is in response to rising trial complexity, shrinking participant per site enrollment, growing regulatory requirements, and higher drug development costs.

Featured in this report are four strategies clinical trial operations leaders can employ in 2019 to meet these rising demands. We compiled these insights from over 25 industry events in 2018, working with over 3,500 clinical trial teams, conducting hundreds of hours of analysis and compliance research.